Achieve Life Sciences, Inc.ACHVNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-29.77M
↓ 42% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-20.90M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $-29.77M | -21.5% |
| 2023 | $-24.50M | +34.8% |
| 2022 | $-37.57M | -27.6% |
| 2021 | $-29.44M | -118.2% |
| 2020 | $-13.49M | +11.6% |
| 2019 | $-15.27M | -43.1% |
| 2018 | $-10.67M | -17.2% |
| 2017 | $-9.11M | +69.4% |
| 2016 | $-29.73M | -213.9% |
| 2015 | $-9.47M | - |